Weight Loss News and Research

Latest Weight Loss News and Research

UH Case Medical Center offers per-oral endoscopic myotomy for achalasia

University Hospitals (UH) Case Medical Center is one of five institutions nationwide performing a novel scarless procedure that restores swallowing function in some patients with achalasia, a rare condition where the esophagus is unable to move food into the stomach.

25 Sep 2012

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

25 Sep 2012

Extended release exenatide outperforms twice daily regimen

Once-weekly extended-release exenatide is a more effective treatment than twice-daily exenatide at improving glucose control among Japanese individuals with diabetes, report researchers.

24 Sep 2012

Interleukin-6 could affect hunger and satiety

Researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden, have identified a molecule in the immune system that could affect hunger and satiety. The researchers hope that new treatments for obesity will benefit from this finding.

24 Sep 2012

Study looks at effect of all dietary antioxidants in relation to myocardial infarction

Coronary heart disease is a major cause of death in women. A new study has found that a diet rich in antioxidants, mainly from fruits and vegetables, can significantly reduce the risk of myocardial infarction.

24 Sep 2012

ChromaDex announces findings from pTeroPure Phase 2/3 trial on high blood pressure

ChromaDex Corporation announced today findings from a Phase 2/3 trial at the University of Mississippi Medical Center showing its patented nutritional ingredient pTeroPure (pterostilbene) significantly reduced blood pressure in adults.

21 Sep 2012

Itrim programme effectively reduces weight among obese people

Anyone who wants to lose weight has a wide variety of diets to choose from, but knowledge of what works is often poor. Researchers at Karolinska Institutet and Uppsala University have now evaluated a Swedish commercial weight loss programme called Itrim, and found it to be effective. After one year, participants had lost 11 kg on average.

21 Sep 2012

Benefits limited of surgery weight loss for sleep apnea

Obese patients with obstructive sleep apnea who lose significant weight through surgery may still not be cured of their sleep disorder, study findings indicate.

20 Sep 2012

Views on obesity: Difficulty changing eating habits; Huge changes in the food marketplace

The New York Times and the Journal of the American Medical Association offer opinions on the U.S. battle against obesity.

20 Sep 2012

Study examines association of Roux-en-Y gastric bypass surgery with weight loss, diabetes mellitus

Severely obese patients who had Roux-en-Y gastric bypass surgery had significant weight loss that was sustained for an average of 6 years after the surgery and also experienced frequent remission and lower incidence of diabetes, hypertension, and abnormal cholesterol levels, compared to participants who did not have the surgery, according to a study in the September 19 issue of JAMA, and theme issue on obesity.

20 Sep 2012

Diabetes risk accumulates with visceral fat

A change in intraabdominal fat area over time is associated with the development of diabetes in Japanese-American individuals, report US researchers.

18 Sep 2012

HSS recognizes Kaiser Permanente Colorado as a 2012 Hypertension Control Champion

Today, U.S. Department of Health and Human Services Secretary Kathleen Sebelius recognized Kaiser Permanente Colorado as a 2012 Million Hearts Hypertension Control Champion. Million Hearts is a national public-private initiative of the U.S. Department of Health and Human Services.

18 Sep 2012

Message delivery vital to successful obesity prevention

The way that an anti-obesity message is delivered to people who are overweight or obese impacts dramatically on how successful campaigns are at motivating people to lose weight, say researchers.

13 Sep 2012

ACO 'predecessor' saved Medicare money, according to JAMA study

The study, found that the Medicare Physician Group Practice Demonstration resulted in health care savings.

13 Sep 2012

Exercise may affect how people respond to food cues

It is commonly assumed that you can "work up an appetite" with a vigorous workout. Turns out that theory may not be completely accurate - at least immediately following exercise.

13 Sep 2012

More patients gain weight after joint replacement surgery

Hip and knee replacements are now a common surgical procedure with more than 700,000 total joint arthroplasties (TJAs) performed in the US every year. Due to the reduction in pain and increases in mobility experienced after having a TJA, it could be expected that weight loss may occur as a by-product of the surgery.

10 Sep 2012

Study finds surprising difference in eating habits of younger and older overweight children

A new study by University of North Carolina School of Medicine pediatrics researchers finds a surprising difference in the eating habits of overweight children between ages 9 and 17 years compared to those younger than 9.

10 Sep 2012

Strong antiviral antibody response observed in oral administration of Flucide

NanoViricides, Inc. announced today that anti-influenza drug candidates under its FluCide program, when given orally, led to strong antiviral antibody response. The antibody response with Oral administration was stronger than that with IV administration and was substantially greater than that observed with oseltamivir.

5 Sep 2012

EC grants European market authorization for Revestive to treat short bowel syndrome

Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.

5 Sep 2012

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

4 Sep 2012